12th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production
DUBLIN, Aug. 28, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/9w6lh9/12th_annual) has announced the addition of the "12th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production" report to their offering.
The 2015 12th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production is the most recent study of biotherapeutic developers and contract manufacturing organizations' current and projected future capacity and production. The report contains the industry's definitive, quantitative analysis and includes 12 years of biopharma trends as well as a review of current opportunities and in-depth coverage by several subject matter experts of critical issues affecting the industry.
The survey includes responses from 237 responsible individuals at biopharmaceutical manufacturers and contract manufacturing organizations from 28 countries. The methodology also includes responses from an additional 164 direct suppliers of raw materials, services and equipment to this industry.
Top trends identified include:
- Focus today is on manufacturing and productivity
- Operations budgets are growing, from R&D to new capital equipment
- Single-use systems and disposable devices among the new bio-innovations most in demand
- U.S. and EU are stepping up their Biosimilars pipeline
- Hiring growing rapidly in key areas; 51% of companies unable to hire the right PD staff
- China is now the #1 "potential" outsourcing destination
- Suppliers are increasing their R&D and focus on improved productivity
- Fill-Finish operations are going high-tech and single-use
- Bioprocessing is getting better as failure rates have been almost cut in half over the past 8 years
Key Topics Covered:
Chapter 1: Introduction and Discussion
Chapter 3: Emerging Issues in Biopharmaceutical Manufacturing
Chapter 4: Capacity Utilization
Chapter 5: Current and Future Capacity Constraints
Chapter 6: Future Capacity Expansions
Chapter 7: Outsourcing Trends in Biopharmaceutical Manufacturing
Chapter 8: Disposables and Single-Use Systems in Biopharmaceutical Manufacturing
Chapter 9: Downstream Purification
Chapter 10: Quality Issues, Batch Failures, and PAT in Biopharmaceutical Manufacturing
Chapter 11: Hiring, Employment Growth, and Training in Biopharmaceutical
Chapter 12: Fill and Finish
Chapter 13: Suppliers to Biopharmaceutical Manufacturing and Life Sciences
For more information visit http://www.researchandmarkets.com/research/9w6lh9/12th_annual
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
Share this article